CSIRO

Funding Success for CFBD Director

/ arccfbd

CFBD Director Prof Martin Scanlon received funding through CSIRO’s CUREator – a national biotechnology incubator run by Brandon BioCatalyst to support the development of Australian biomedical research and innovations.

The project is led by Prof Bernie Flynn (Monash), Prof Colin Pouton (Monash) and CFBD Director Prof Martin Scanlon. The funding will support their aim to respond to the risk of viral and bacterial replication through the development of a platform capability in polynucleotide fragment based drug design (pFBDD) that is better able to discover small-molecules for targeting RNA and DNA.

CUREator is delivered through an initial $40m in funding from the Federal Government’s Medical Research Future Fund (MRFF) and $3m from Australia’s national science agency, CSIRO. CUREator was established by Brandon Capital in 2021 as a new approach for bridging the gap between where research grant funding ends and commercial investment begins.

2023 Inspiring Leadership Award

/ arccfbd

Congratulations to our Partner Investigator Professor Susie Nilsson from CSIRO for receiving the 2023 Inspiring Leadership Award from the BioMelbourne Network

Image credit: https://biomelbourne.org/women-in-leadership-awards/women-in-leadership-awards-honour-roll/

Launched in 2015, BioMelbourne Network’s Women in Leadership Awards recognise and champion women who are making outstanding contributions to the health-tech industry. The 2023 Awards Ceremony honoured three remarkable leaders, at different stages of their careers, who have taken strategic risks, tenaciously pursued goals and served as role models to the younger generation.

Susie Nilsson received the award in the category “Inspiring Leadership Award – Making it Happen”. This award recognises women playing an inspiring and pivotal role in the leadership of a project, partnership or collaborative initiative, approximately within the last 5-10 years.